To determine if JNK/p38 MAPK activation was a key event in P1446A-induced apoptosis, CLL cells were treated with corresponding pharmacologic inhibitors, resulting in partial protection from cell death (Fig 3E). The gene discussed is MAPK8; the disease is B-cell chronic lymphocytic leukemia.